Satavaptan Dose-Ranging Study in the Prevention of Ascites

PHASE2CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
AscitesLiver Cirrhosis
Interventions
DRUG

satavaptan (SR121463B)

Trial Locations (11)

Unknown

Sanofi-Aventis Administrative Office, Buenos Aires

Sanofi-Aventis Administrative Office, Cove

Sanofi-Aventis Administrative Office, Diegem

Sanofi-Aventis Administrative Office, Laval

Sanofi-Aventis Administrative Office, Zagreb

Sanofi-Aventis Administrative Office, Prague

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Milan

Sanofi-Aventis Administrative Office, Barcelona

Sanofi-Aventis Administrative Office, Taipei

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00501384 - Satavaptan Dose-Ranging Study in the Prevention of Ascites | Biotech Hunter | Biotech Hunter